Sabra Health Care REIT Inc expected to post earnings of 16 cents a share - Earnings Preview

Sabra Health Care REIT

18/02/2025 24:03

* Sabra Health Care REIT Inc  SBRA.OQ   SBRA.O  is expected
to show a rise in quarterly revenue when it reports  results on
February 20 for the period ending December 31 2024
    * The Tustin California-based  company is expected to report
a
8.9% increase in revenue to $177.962 million from $163.4 million
a year ago, according to the mean estimate from 8 analysts,
based on LSEG data. (SAL Represents Rental revenue/ Total
revenue)
    * ​LSEG's mean analyst estimate for Sabra Health Care REIT
Inc is
for earnings of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $20.00​, above​ its last closing price of $16.52.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  0.35        0.35       0.35      Met     1.1
 Jun. 30 2024  0.35        0.34       0.35      Beat    1.6
 Mar. 31 2024  0.33        0.33       0.34      Beat    2.7​
 Dec. 31 2023  0.33        0.33       0.32      Missed  -3.2
 ​​Sep.        0.33        0.33       0.33      Met     -0.8
 30 2023                                                
 Jun. 30 2023  0.33        0.33       0.33      Met     -1.3​
 Mar. 31 2023  0.34        0.34       0.33      Missed  -4
 Dec. 31 2022  0.35        0.36       0.37      Beat    4.1
 This summary was machine generated February 18 at 00:02 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)